Search
for
Sort by
Research 30 of 254
- Clinical and immunologic parameters during thalidomide treatment of lupus erythematosus
- Lichen planopilaris treated with thalidomide
- Selective Sensing of Darolutamide and Thalidomide in Pharmaceutical Preparations and in Spiked Biofluids
- Effect of thalidomide combined with CHOP on patients with peripheral T-cell lymphoma
- Lichen planus
- Lupus erythematosus: systemic and cutaneous manifestations
- Management of primary cicatricial alopecias: options for treatment
- Primary cicatricial alopecia
- Cutaneous lupus erythematosus
- Early Diagnosis and Treatment of Discoid Lupus Erythematosus
- Management of ‘refractory’ skin disease in patients with lupus erythematosus
- Infertility and teratogenicity after paternal exposure to systemic dermatologic medications: A systematic review
- Characteristics and Alternative Treatment Outcomes of Antimalarial-Refractory Cutaneous Lupus Erythematosus
- Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects
- Cutaneous Involvement in Systemic Lupus Erythematosus: A Review for the Rheumatologist
- Brazilian blood donation eligibility criteria for dermatologic patients
- Cicatricial alopecia
- Recent Insight on the Management of Lupus Erythematosus Alopecia
- LUPUS ERYTHEMATOSUS AND THE SKIN
- Review of Drug Repositioning in Cancer Therapeutics
- Tumor necrosis factor inhibitors and janus kinase inhibitors in the treatment of cicatricial alopecia: A systematic review
- Discoid Lupus Erythematosus of the Scalp in a Patient with Systemic Lupus Erythematosus: A Case Report with Complete Hair Regrowth
- Cutaneous Lupus Erythematosus
- Cutaneous Manifestations of Lupus Erythematosus
- Decades of progressive red and yellow nodules
- Behcet's disease and complex aphthosis
- Repositioning Old Drugs for New Battles: The Expanding Role of Drug Repurposing in Cancer, Inflammation, and Metabolic Disease.
- Drug repurposing: Clinical practices and regulatory pathways
- Recent Insights in Multi‐Target Drugs in Pharmacology and Medicinal Chemistry
- Why Do Promising Therapies Stall in Development and How Can We Move Them Forward?